×
Well done. You've clicked the tower. This would actually achieve something if you had logged in first. Use the key for that. The name takes you home. This is where all the applicables sit. And you can't apply any changes to my site unless you are logged in.

Our policy is best summarized as "we don't care about _you_, we care about _them_", no emails, so no forgetting your password. You have no rights. It's like you don't even exist. If you publish material, I reserve the right to remove it, or use it myself.

Don't impersonate. Don't name someone involuntarily. You can lose everything if you cross the line, and no, I won't cancel your automatic payments first, so you'll have to do it the hard way. See how serious this sounds? That's how serious you're meant to take these.

×
Register


Required. 150 characters or fewer. Letters, digits and @/./+/-/_ only.
  • Your password can’t be too similar to your other personal information.
  • Your password must contain at least 8 characters.
  • Your password can’t be a commonly used password.
  • Your password can’t be entirely numeric.

Enter the same password as before, for verification.
Login

Grow A Dic
Define A Word
Make Space
Set Task
Mark Post
Apply Votestyle
Create Votes
(From: saved spaces)
Exclude Votes
Apply Dic
Exclude Dic

Click here to flash read.

Research in the International Journal of Computational Biology and Drug Design, has looked at the potential of various bioflavonoids as inhibitors of the SARS-CoV-2 virus, which causes COVID-19. The compounds—narirutin, naringin, neohesperidin and hesperidin—are found in citrus fruits. Their wide-ranging therapeutic and physiological effects are well known. The possibility of repurposing them in the face of the ongoing pandemic is discussed in light of computer modeling of their interaction with the virus' infamous spike protein.

Click here to read this post out
ID: 114323; Unique Viewers: 0
Unique Voters: 0
Total Votes: 0
Votes:
Latest Change: May 9, 2023, 7 a.m. Changes:
Dictionaries:
Words:
Spaces:
Views: 11
CC:
No creative common's license
Comments: